Iatrogenic Cerebral Amyloid Angiopaty Post Neurosurgery:Frequency, Clinical Profile, Radiological Features, and Outcome
Stroke 54:1214-1223, 1224, Kaushik,K.,et al, 2023
Mortality, Neoplasia, & Creutzfeldt-Jakob Disease in Patients Treated with Human Pituitary Growth Hormone in the UK
BMJ 302:824-828, Buchanan,C.R.,et al, 1991
Acromegaly
NEJM 322:966-977, Melmed,S., 1990
Acromegaly
NEJM 355:2558-2573, Melmed,S., 2006
14-3-3 Protein Cerebrspinal Fluid Detection in Human Growth Hormone-Treated Creutzfeldt-Jakob Disease Patients
Ann Neurol 49:257-260, Brandel,J.,et al, 2001
Iatrogenic Creutzfeldt-Jakob Disease at the Millenium
Neurol 55:1075-1081, Brown,P.,et al, 2000
Pituitary Surgery for Acromegaly, Should be Done by Specialists
BMJ 319:588-589, Clayton,R.N.,et al, 1999
A Randomized, Double-Blind, Placebo-Controlled Study of Growth Hormone in the Treatment of Fibromyalgia
Am J Med 104:227-231, Bennett,R.M.,et al, 1998
Creutzfeldt-Jakob Disease and Related Transmissible Spongiform Encephalopathies
NEJM 339:1994-2004, Johnson,R.T. & Gibbs,Jr.,C.J., 1998
Long-Term Octreotide Therapy in Growth Hormone-Secreting Pituitary Adenomas:Evaluation with Serial MR
AJNR 18:765-772, Lundin,P.,et al, 1997
Creutzfeldt-Jakob Disease from Contaminated Growth Hormone Extracts in France
Neurol 47:690-695, Billette de Villemeur,T.,et al, 1996
Benign Intracranial Hypertension in Children with Growth Hormone Deficiency Treated with Growth Hormone
J Pediatr 126:996-999, Malozowski,S.,et al, 1995
Effect of Octreotide, A Somatostatin Analog, on Sleep Apnea in Patients with Acromegaly
Ann Int Med 121:478-483, Grunstein,R.R.,et al, 1994
Acromegaly:Clinical and Biochemical Features in 500 Patients
Medicine 73:233-240, Ezzat,S.,et al, 1994
Hypopituitarism After Tuberculous Meningitis in Childhood
Ann Int Med 118:701-706, Lam,K.S.L.,et al, 1993
Acromegaly:Treatment After 100 Years
BMJ 307:1505-1506, Wass,J.A.H., 1993
"Friendly Fire"in Medicine:Hormones, Homografts, and Creutzfeldt-Jakob Disease
Lancet 340:24-27, Brown,P.,et al, 1992
Octreotide Treatment of Acromegaly, A Randomized, Multicenter Study
Ann Int Med 117:711-718, Ezzat,S.,et al, 1992
Creutzfeldt-Jakob Disease in Pituitary Growth Hormone Recipients in the United States
JAMA 265:880-884, Fradkin,J.E.,et al, 1991
Diagnosis and Management of Hormone-Secreting Pituitary Adenomas
NEJM 324:822-831, Klibanski,A.&Zervas,N.T., 1991
Genetic Predisposition to Iatrogenic Creutzfeldt-Jakob Disease
Lancet 337:1441-1442, Collinge,J.,et al, 1991
Human Growth Hormone Therapy & Creutzfeldt-Jakob Disease:A Drama in Three Acts
Pediatrics 81:85-92, Brown,P., 1988
The Decline and Fall of Creutzfeldt-Jakob Disease Associated with Human Growth Hormone Therapy
Neurol 38:1135-1137, Brown,P., 1988
Creutzfeldt-Jakob Disease Following Pituitary-Derived Human Growth Hormone Therapy:A New American Case
Neurol 38:1131-1133, Marzewski,D.J.,et al, 1988
Iatrogenic Creutzfeldt-Jakob Disease
Neurol 37:1520-1522, Rappaport,E.B., 1987
Creutzfeldt-Jakob Disease after Administration of Human Growth Hormone
Lancet 2:244-246, Powell-Jackson,J.,et al, 1985
Human Growth Hormone & Creutzfeldt-Jakob Disease
Ann Int Med 103:288-289, Raiti,S., 1985
Creutzfeldt-Jakob Disease in a Young Adult with Idiopathic Hypopituitarism, Relation to Growth Hormone
NEJM 313:731-733, Koch,T.K.,et al, 1985
Clinical & Path Features & Lab Confirmation of Creutzfeldt-Jakob Disease with Pituitary Derived Human Growth Hormone
NEJM 313:734-738, Gibbs,C.J.,et al, 1985
Potential Epidemic of Creutzfeldt-Jakob Disease from Human Growth Hormone Therapy
NEJM 313:728-731, Brown,P.,et al, 1985
Drug Therapy, Bromocriptine
NEJM 301:873-878, Parkes,D., 1979